The abstract is read at the publisher; the summary is JClub's.
Campylobacter jejuni and Campylobacter coli cause an estimated 500 million acute diarrheal illness cases annually worldwide, yet no licensed vaccine exists and antimicrobial resistance is rising.
- Why it matters: The lack of a vaccine and the threat of antimicrobial resistance complicate management of a major global pathogen linked to severe post-infectious sequelae like Guillain-Barré syndrome.
- What they did: This review synthesizes One Health genomic epidemiology, antimicrobial resistance mechanisms, and vaccine development approaches, emphasizing integrated genomic surveillance across human, animal, and environmental reservoirs.
- The result: Genomics-informed interventions show promise in poultry and human contexts, and continued investment in genomic surveillance, antimicrobial resistance research, and rational antigen selection is positioned as essential for effective vaccine development.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.